These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19955921)

  • 1. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
    Ogata S; Morishige K; Sawada K; Hashimoto K; Mabuchi S; Kawase C; Ooyagi C; Sakata M; Kimura T
    Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
    Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
    Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.
    Sawada K; Morishige K; Tahara M; Kawagishi R; Ikebuchi Y; Tasaka K; Murata Y
    Cancer Res; 2002 Nov; 62(21):6015-20. PubMed ID: 12414621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geranylgeranylacetone inhibits lysophosphatidic acid-induced invasion of human ovarian carcinoma cells in vitro.
    Hashimoto K; Morishige K; Sawada K; Tahara M; Shimizu S; Sakata M; Tasaka K; Murata Y
    Cancer; 2005 Apr; 103(7):1529-36. PubMed ID: 15739201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
    Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil protects cultured N1E-115 cells against lysophosphatidic acid-induced neurite retraction through inhibition of Rho-kinase.
    Satoh S; Kawasaki K; Hitomi A; Ikegaki I; Asano T
    Brain Res Bull; 2011 Feb; 84(2):174-7. PubMed ID: 21126559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
    Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
    Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
    Guerra FS; Oliveira RG; Fraga CAM; Mermelstein CDS; Fernandes PD
    Sci Rep; 2017 Oct; 7(1):13723. PubMed ID: 29057980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
    Yang X; Zhang Y; Wang S; Shi W
    Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
    Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fasudil inhibits HSC adhesion, migration and proliferation via Rho/ROCK pathway].
    Wang YZ; Jiang HQ; Hu CX; Chen X
    Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):821-3. PubMed ID: 17125608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
    Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
    Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
    Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
    Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
    Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt-signaling mediates the anti-adipogenic action of lysophosphatidic acid through cross talking with the Rho/Rho associated kinase (ROCK) pathway.
    Li L; Tam L; Liu L; Jin T; Ng DS
    Biochem Cell Biol; 2011 Dec; 89(6):515-21. PubMed ID: 21999426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells.
    Negoro N; Hoshiga M; Seto M; Kohbayashi E; Ii M; Fukui R; Shibata N; Nakakoji T; Nishiguchi F; Sasaki Y; Ishihara T; Ohsawa N
    Biochem Biophys Res Commun; 1999 Aug; 262(1):211-5. PubMed ID: 10448094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.